Fundraising FoxZBeats
1 known investors
Find your way into ZBeats
Sign up to see every warm intro you have to ZBeats
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ZBeats team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows. The platform serves healthcare organizations, remote patient monitoring providers, diagnostic testing facilities, and medical device manufacturers with arrhythmia detection and data integration capabilities.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2022 | $314.6K |
| National Science Foundation | Phase I | 2020 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does ZBeats do?
- ZBeats is a cardiac technology company offering FDA-cleared electrocardiographic analysis software that transforms ECG signals into structured clinical intelligence for cardiology workflows. The platform serves healthcare organizations, remote patient monitoring providers, diagnostic testing facilities, and medical device manufacturers with arrhythmia detection and data integration capabilities.
- Who are ZBeats's investors?
- ZBeats's investors include Camellia Venture Capital.